Openbookopenbook
Equity
Carl Zeiss Meditec AG ADR(CZMWY)
USD --+0.00%
Reward57Moderate
Risk36Moderate
📊75%Data
2.1% dividend yield
CZMWY
+0.0 · +0.00%
USD · PINK
Carl Zeiss Meditec AG ADR | Healthcare
Deep Value
Market Cap:2.74Bn
ℹ️
Reward Rating
57
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
36
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on CZMWY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Carl Zeiss Meditec AG ADR?

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia.

CZMWY · Verdict

Solid reward · moderate risk

CZMWY stands out on balance sheet and valuation, but watch the volatility signal.

Based on 88% data coverage

CZMWY · Verdict

What’s working & what to watch

Strengths 3

  • Balance sheet83/100

    Interest covered 7.5×

  • Valuation80/100

    P/E 20.7× · PEG 1.19

  • Cash flow67/100

    8% free-cash-flow margin

Watchouts 1

  • Volatility35/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Carl Zeiss Meditec AG ADR?

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.74B, and a P/E ratio of 16.5x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (57)

The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.74B
P/E Ratio16.4816
Dividend Yield2.06%
52 Week High75.0381
52 Week Low29.92
Last AnnualSeptember
IPO DateN/A
IncorporatedUSA
Shares Outstanding88M
No. of Employees5,784
IndustryMedical Instruments & Supplies
ExchangePINK
Beta1.435
CurrencyUSD · Reports in EUR
Websitewww.zeiss.com/meditec-ag/de/investor-relat
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.